Terry Monks

“Advancing Prostate Cancer Research in Health Disparate and World Populations Utilizing Unrelated and Family Data”

September 2, 2015 - 12:00pm - 1:30pm
Terry Monks
Cheryl Cropp
UA Phoenix

Continued funding for Liver/kidney on-a-chip for environmental toxicology studies



Jay Gandolfi, Ph.D.
Research Professor
Center for Toxicology

Terrence Monks, Ph.D.
Pharmacology and Toxicology



Jeong- Yeol Yoon, Ph.D.
Agric & Biosystems Engr-Res


Amount of funding received:



UA Science Internship Pairs High School Students, Research Mentors

News Date: 
June 3, 2013 :00am

Each year many SWEHSC researchers host high school students in their laboratories. Facility managers assits them process their samples and understand their data. SWEHSC members teach them about toxicology and environmental health. The program was designed by the SWEHSC Outreach Core and is conducted in collaboration with the BIO5 Instutue. Read more about this year's program


The SWEHSC plays an important role in stimulating collaborative interactions among researchers. This is evidenced by a significant number of new, funded research projects, as well as a notable number of planned initiatives involving collaborations. The SWEHSC promotes and enhances collaborative research within and between the members through Research Focus Groups.

The themes of the three Research Focus Groups are seen below.

In the Parmacy Spotlight

Brian Erstad, PharmD, has been selected as head of the Department of Pharmacy Practice and Science in the College of Pharmacy effective March 18. A member of the department since 1988, Erstad has served as interim head since February 2012. He was assistant department head from 1997 through 2011. He also is a clinical pharmacist in critical care at the University of Arizona Medical Center-University Campus and the program director of the college’s Postgraduate Year Two Critical Care Pharmacy Residency there.

Monks to Study the Adverse Effects of Ecstasy

The National Institute on Drug Abuse has awarded Terrence Monks, head of the Department of Pharmacology and Toxicology at The University of Arizona College of Pharmacy, $1.7 million for a nearly five-year study of the long-term adverse effects of the street drug Ecstasy, also known as the “hug drug.”

Read more here

Syndicate content